Gaucher Patients Cope With Drug Shortage, as New Treatments Beckon
For thousands of people with Gaucher disease, the most common genetic disorder affecting Jews, the next few months will be challenging. Many are going without the drug used to treat their potentially life-threatening enzyme disorder, after a virus contaminated a Boston-area manufacturing plant of biotechnology company Genzyme. Meanwhile, Gaucher patients and their doctors are watching…